Total Utang marang Modal Biomerica (BMRA)

BMRA (biomerica.com) - tandha merek perusahaan

This price chart shows that Biomerica, Inc. (BMRA) maintains a debt-to-equity ratio of 0.61. The business relies on partnerships with pharmacies and clinics to promote rapid diagnostics. High profitability is driven by the mass sale of consumables for its proprietary test systems. The company is currently expanding its list of insurance-approved products for detecting food intolerances.

BMRA: Rasio Utang marang Ekuitas biomerica.com 04.07.2022 - 31.10.2026

Rincian analitis perusahaan Biomerica Inc (BMRA)

- rega lan prakiraan konsensus rega:
Bagan rega Biomerica|BMRA - Target konsensus
- rincian kapitalisasi pasar:
Kapitalisasi pasar Biomerica|BMRA - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Buku saben Saham Biomerica|BMRA - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku biomerica.com|BMRA - Total Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Biomerica, Inc.|BMRA - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Biomerica, Inc.|BMRA - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Biomerica|BMRA - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Biomerica|Likuiditas cepet biomerica.com
- informasi bathi lan kelipatan valuasi:
BMRA - Asil keuangan resik
Analisis dhasar perusahaan:BMRA, Biomerica
Barang utama Biomerica Inc

This ratio measures the proportion of borrowed funds in the asset financing structure relative to equity, determining the degree of financial leverage and bankruptcy risk. By analyzing the ratio of total debt to equity, an investor assesses the stability of Biomerica, Inc. (BMRA) during its transition from expansion via acquisitions to organic growth and profit optimization through pharmacy distribution.

Pesaing wigati

Utang marang Ekuitas Agilent|Rasio Total Utang marang Ekuitas Quest Diagnostics Inc. (DGX)|Total Utang marang Modal ILMN|EXAS - Utang marang Modal|Total Utang marang Modal RVTY (Revvity, Inc.)|BIO: Rasio Utang marang Ekuitas|Anbio - Total Utang marang Modal|SHC - Total Utang marang Modal|QuidelOrtho Corp (QDEL) - Utang marang Ekuitas|Rasio Utang marang Ekuitas OPK|CDNA (CareDx Inc) - Total Utang marang Modal|Total Utang marang Modal maravai.com|Utang marang Ekuitas Fulgent Genetics (FLGT)|Utang marang Ekuitas LAB (Standard BioTools Inc)|Cytek Bio - Rasio Total Utang marang Ekuitas|OraSure Corp (OSUR) - Utang marang Modal|XGN - Utang marang Ekuitas|Koefisien Total Utang marang Modal mdxhealth.com MDXH|LUCD: Total Utang marang Modal|PRE - Koefisien Total Utang marang Modal|Utang marang Ekuitas Insight Molecular Diagnostics, Inc.|Trinity Biotech Corp (TRIB) - Koefisien Total Utang marang Modal|Total Utang marang Modal PRPH|Utang marang Ekuitas AIMD (ainos.com)|Total Utang marang Modal CODX (Co-Diagnostics)|Koefisien Total Utang marang Modal Heart Test Laboratories, Inc. (HSCS)|CDIO - Utang marang Ekuitas|Utang marang Modal Virax Biolabs Corp|Bluejay Diagnostics (BJDX) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas aspirawh.com|AXDX (Accelerate Diagnostics, Inc.) - Total Utang marang Modal|Utang marang Modal Centogene NV CNTG|Utang marang Ekuitas Enzo Biochem, Inc. (ENZ)|FRES (fresh2.co) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal GENE (Genetic Technologies Limited)|Koefisien Total Utang marang Modal 23andme.com (ME)|Psychemedics Corporation - Total Utang marang Modal